| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115
The binding of MDM2 targets p53, but not p73, for degradation, whereas it suppresses the transactivation function of both proteins. MDM2 also mediates p53 nuclear export, but its role in the regulation of p73 distribution is unknown at the present time. We show here that, in sharp contrast to p53, MDM2 induces p73 to form nuclear aggregates that colocalize with MDM2 but are distinct from the promyelocytic leukemia dots. The MDM2 ring-domain that is necessary for mediating p53 nuclear export is not required for the induction of the p73 nuclear aggregates. Using a domain-swapping approach, we demonstrate that the inability of p73 to nuclear-export is attributable to its nonfunctional nuclear-export sequence.
This article has been cited by other articles:
![]() |
X.-Z. Chi, J. Kim, Y.-H. Lee, J.-W. Lee, K.-S. Lee, H. Wee, W.-J. Kim, W.-Y. Park, B.-C. Oh, G. S. Stein, et al. Runt-Related Transcription Factor RUNX3 Is a Target of MDM2-Mediated Ubiquitination Cancer Res., October 15, 2009; 69(20): 8111 - 8119. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Malaguarnera, V. Vella, G. Pandini, M. Sanfilippo, V. Pezzino, R. Vigneri, and F. Frasca TAp73{alpha} Increases p53 Tumor Suppressor Activity in Thyroid Cancer Cells via the Inhibition of Mdm2-Mediated Degradation Mol. Cancer Res., January 1, 2008; 6(1): 64 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Watson, A. Blanch, D. C. C. Lin, M. Ohh, and M. S. Irwin Mdm2-mediated NEDD8 Modification of TAp73 Regulates Its Transactivation Function J. Biol. Chem., November 10, 2006; 281(45): 34096 - 34103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brady, N. Vlatkovic, and M. T. Boyd Regulation of p53 and MDM2 Activity by MTBP Mol. Cell. Biol., January 15, 2005; 25(2): 545 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, S. Nozell, H. Xiao, and X. Chen {Delta}Np73{beta} Is Active in Transactivation and Growth Suppression Mol. Cell. Biol., January 15, 2004; 24(2): 487 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. C. Tsai and Z.-M. Yuan c-Abl Stabilizes p73 by a Phosphorylation-augmented Interaction Cancer Res., June 15, 2003; 63(12): 3418 - 3424. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inoue, J. Stuart, R. Leno, and C. G. Maki Nuclear Import and Export Signals in Control of the p53-related Protein p73 J. Biol. Chem., April 19, 2002; 277(17): 15053 - 15060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. E. Lohrum, D. B. Woods, R. L. Ludwig, E. Balint, and K. H. Vousden C-Terminal Ubiquitination of p53 Contributes to Nuclear Export Mol. Cell. Biol., December 15, 2001; 21(24): 8521 - 8532. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gu, L. Nie, D. Wiederschain, and Z.-M. Yuan Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export Mol. Cell. Biol., December 15, 2001; 21(24): 8533 - 8546. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Calabro, G. Mansueto, T. Parisi, M. Vivo, R. A. Calogero, and G. La Mantia The Human MDM2 Oncoprotein Increases the Transcriptional Activity and the Protein Level of the p53 Homolog p63 J. Biol. Chem., January 18, 2002; 277(4): 2674 - 2681. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |